Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 326

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 3
Chunk 326
---
 sale of businesses38 (87)N/M79 (106)N/MNet investment gains (losses)26 (921)N/M76 (2,805)N/MIncome before income taxes2,295 1,192 93 5,964 3,260 83 Total income taxes322 367 (12)950 1,018 (7)Net income1,973 825 139 5,014 2,242 124 Less: Net income attributable to noncontrolling interests105 86 22 291 232 25 Shareholders' net income$1,868 $739 153 %$4,723 $2,010 135 %Consolidated effective tax rate14.0 %30.8 %(1,680)bps15.9 %31.2 %(1,530)bpsMedical customers (in thousands)18,059 19,048 (5)%

36

Reconciliation of Shareholders' Net Income (GAAP) to Adjusted Income from OperationsThree Months Ended September 30,Nine Months Ended September 30,2025202420252024(In millions)Pre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxShareholders' net income$1,868 $739 $4,723 $2,010 Adjustments to reconcile to adjusted income from operationsNet investment (gains) losses (1)$(204)(43)$744 740 $(348)(194)$2,567 2,547 Amortization of acquired intangible assets436 332 436 333 1,280 998 1,279 972 Special itemsStrategic optimization program222 168 — — 566 429 — — Integration and transaction-related costs7 6 77 59 297 226 177 135 (Gain) loss on sale of businesses (38)(241)87 62 (79)(356)106 19 (Benefits) associated with litigation matters(17)(13)— — (17)(13)— — Deferred tax expenses, net (2)— 19 — 41 — 53 — 75 Impairment of dividend receivable — — 182 138 — — 182 138 Total special items$174 (61)$346 300 $